Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lu Di, Kai Qian, Chengrun Du, Chunying Shen, Ruiping Zhai, Xiayun He, Xiaoshen Wang, Tingting Xu, Chaosu Hu & Hongmei Ying. (2018) Radiotherapy as salvage treatment of salivary duct carcinoma in major salivary glands without radical operations. Cancer Management and Research 10, pages 6071-6078.
Read now
Read now
Articles from other publishers (42)
Juliana Mota Siqueira, Yoshitsugu Mitani, Camilla Oliveira Hoff, Flavia Bonini, Luana Guimaraes de Sousa, Mario L. Marques-Piubelli, Anurag Purushothaman, Mutsumi Mitani, Hui Dai, Shiaw-Yih Lin, Michael T. Spiotto, Ehab Y. Hanna, Daniel J. McGrail, Adel K. El-Naggar & Renata Ferrarotto. (2024) Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma–Specific Prognostic Relevance. Modern Pathology 37:1, pages 100371.
Crossref
Crossref
Yoshitsugu Horio, Hiroaki Kuroda, Katsuhiro Masago, Hirokazu Matsushita, Eiichi Sasaki & Yutaka Fujiwara. (2023) Current diagnosis and treatment of salivary gland-type tumors of the lung. Japanese Journal of Clinical Oncology.
Crossref
Crossref
Conor E. Steuer, Glenn J. Hanna, Kartik Viswanathan, James E. Bates, Azeem S. Kaka, Nicole C. Schmitt, Alan L. Ho & Nabil F. Saba. (2023) The evolving landscape of salivary gland tumors. CA: A Cancer Journal for Clinicians 73:6, pages 597-619.
Crossref
Crossref
Gang Qin, Lei Wu, Chengxia Li, Qian Zhang, Zhongjun An & Jianhua Qin. (2023) Prognostic factors for sublingual gland carcinoma: a population-based Surveillance, Epidemiology and End Results database study. Journal of International Medical Research 51:11.
Crossref
Crossref
Ryutaro Onaga, Tomohiro Enokida, Kazue Ito, Yuri Ueda, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Naohiro Takeshita, Nobukazu Tanaka, Yuta Hoshi & Makoto Tahara. (2023) Combination chemotherapy with taxane and platinum in patients with salivary gland carcinoma: a retrospective study of docetaxel plus cisplatin and paclitaxel plus carboplatin. Frontiers in Oncology 13.
Crossref
Crossref
Yuichiro TADA. (2023) Systemic therapy for salivary gland carcinoma唾液腺癌に対する全身薬物治療 Up to date. Japanese Journal of Oral and Maxillofacial Surgery 69:4, pages 178-184.
Crossref
Crossref
雄一郎 多田. (2023) 唾液腺癌に対する新たな薬物療法. Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo) 126:2, pages 88-99.
Crossref
Crossref
Naoki Fukuda, Ryosuke Oki, Hirotaka Suto, Xiaofei Wang, Tetsuya Urasaki, Yasuyoshi Sato, Kenji Nakano, Mayu Yunokawa, Makiko Ono, Junichi Tomomatsu, Hiroki Mitani & Shunji Takahashi. (2023) Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck. Oncology 101:8, pages 502-511.
Crossref
Crossref
Alec J. Kacew & Glenn J. Hanna. (2023) Systemic and Targeted Therapies in Adenoid Cystic Carcinoma. Current Treatment Options in Oncology 24:1, pages 45-60.
Crossref
Crossref
Robbert Cleymaet, Tijl Vermassen, Renaat Coopman, Hubert Vermeersch, Stijn De Keukeleire & Sylvie Rottey. (2022) The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?. International Journal of Molecular Sciences 23:23, pages 14891.
Crossref
Crossref
Elena Colombo, Charlotte Van Lierde, Alexandra Zlate, Alexandra Jensen, Gemma Gatta, Fabio Didonè, Lisa F. Licitra, Vincent Grégoire, Vander Vander Poorten & Laura D. Locati. (2022) Salivary gland cancers in elderly patients: challenges and therapeutic strategies. Frontiers in Oncology 12.
Crossref
Crossref
Rex H. Lee, Katherine C. Wai, Jason W. Chan, Patrick K. Ha & Hyunseok Kang. (2022) Approaches to the Management of Metastatic Adenoid Cystic Carcinoma. Cancers 14:22, pages 5698.
Crossref
Crossref
Luana Guimaraes de Sousa, Katarina Jovanovic & Renata Ferrarotto. (2022) Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments. Current Treatment Options in Oncology 23:8, pages 1135-1150.
Crossref
Crossref
Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, Kazuto Matsuura, Ichiro Ota, Yuki Saito, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Koichi Yasuda, Shunji Takahashi, Tomoya Yokota, Susumu Okano, Kaoru Tanaka, Takuma Onoe, Yosuke Ariizumi & Akihiro Homma. (2022) Systemic therapy for salivary gland malignancy: current status and future perspectives. Japanese Journal of Clinical Oncology 52:4, pages 293-302.
Crossref
Crossref
M.J.M. Uijen, G. Lassche, A.C.H. van Engen-van Grunsven, C.M.L. Driessen & C.M.L. van Herpen. (2022) Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinoma. Oral Oncology 125, pages 105703.
Crossref
Crossref
Luana G. Sousa, Kaiwen Wang, Danice Torman, Bailee J. Binks, Maria Laura Rubin, Clark R. Andersen, Whitney E. Lewis, Melvin J. Rivera, Diana Kaya, Adel K. El‐Naggar, Ehab Y. Hanna, Bita Esmaeli, Steven J. Frank, Diana Bell, Bonnie S. Glisson, Jordi Rodon, Funda Meric‐Bernstam, J. Jack Lee & Renata Ferrarotto. (2021) Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified. Cancer 128:3, pages 509-518.
Crossref
Crossref
Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome & Yuichiro Tada. (2022) Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma. Therapeutic Advances in Medical Oncology 14, pages 175883592211195.
Crossref
Crossref
Tarek Taha & Salem Billan. (2021) Case report: ado-trastuzumab as second-line treatment in HER2 positive salivary duct carcinoma. Anti-Cancer Drugs 33:1, pages e760-e763.
Crossref
Crossref
Stephan Hackenberg, Agmal Scherzad & Rudolf Hagen. 2022. Medikamentöse Tumortherapie von Kopf-Hals-Tumoren. Medikamentöse Tumortherapie von Kopf-Hals-Tumoren
189
204
.
Yoshinori Imamura, Kaoru Tanaka, Naomi Kiyota, Hidetoshi Hayashi, Ichiro Ota, Akihito Arai, Shigemichi Iwae, Shujiro Minami, Katsunari Yane, Tomoko Yamazaki, Yoshiaki Nagatani, Masanori Toyoda, Takayuki Takahama, Kazuko Sakai, Kazuto Nishio, Naoki Otsuki, Ken-ichi Nibu & Hironobu Minami. (2021) Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial. Medical Oncology 38:11.
Crossref
Crossref
Vatche Tchekmedyian. (2021) Salivary Gland Cancers. Hematology/Oncology Clinics of North America 35:5, pages 973-990.
Crossref
Crossref
Naoki Fukuda, Yu Fujiwara, Xiaofei Wang, Akihiro Ohmoto, Tetsuya Urasaki, Naomi Hayashi, Yasuyoshi Sato, Kenji Nakano, Mayu Yunokawa, Makiko Ono, Junichi Tomomatsu & Shunji Takahashi. (2020) Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel. European Archives of Oto-Rhino-Laryngology 278:8, pages 3037-3043.
Crossref
Crossref
Jessica L. Geiger, Nofisat Ismaila, Beth Beadle, Jimmy J. Caudell, Nicole Chau, Daniel Deschler, Christine Glastonbury, Marnie Kaufman, Eric Lamarre, Harold Y. Lau, Lisa Licitra, Michael G. Moore, Cristina Rodriguez, Anna Roshal, Raja Seethala, Paul Swiecicki & Patrick Ha. (2021) Management of Salivary Gland Malignancy: ASCO Guideline. Journal of Clinical Oncology 39:17, pages 1909-1941.
Crossref
Crossref
Doreen Palsgrove, Sameer Allahabadi & Saad A. Khan. (2021) Genomic Analysis of Salivary Gland Cancer and Treatment of Salivary Gland Cancers. Surgical Pathology Clinics 14:1, pages 151-163.
Crossref
Crossref
Rieko Ii, Bungo Nishimura, Masahiro Nakayama, Tetsuro Wada & Keiji Tabuchi. (2021) A Case of Giant Pleomorphic Adenoma of the Parotid Gland with Multiple Distant Metastases多発遠隔転移をきたした巨大耳下腺多形腺腫例. Practica Oto-Rhino-Laryngologica 114:6, pages 467-474.
Crossref
Crossref
Sujung Park. 2021. Surgery of the Salivary Glands. Surgery of the Salivary Glands
353
357
.
P. Poxleitner, K. Shoumariyeh, D. Steybe, V. Hupfer, P.J. Voss, J. Rawluk, M. Ermer, C. Miething, R. Schmelzeisen & J. Duyster. (2020) Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma – a case report and review of the literature. Journal of Stomatology, Oral and Maxillofacial Surgery 121:5, pages 599-603.
Crossref
Crossref
Larissa Di Villeneuve, Ive Lima Souza, Fernanda Davila Sampaio Tolentino, Renata Ferrarotto & Gustavo Schvartsman. (2020) Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease. Frontiers in Oncology 10.
Crossref
Crossref
Masato Nakaguro, Yuichiro Tada, William C. Faquin, Peter M. Sadow, Lori J. Wirth & Toshitaka Nagao. (2020) Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathology 128:10, pages 693-703.
Crossref
Crossref
M.J.M. Uijen, G. Lassche, A.C.H. van Engen-van Grunsven, Y. Tada, G.W. Verhaegh, J.A. Schalken, C.M.L. Driessen & C.M.L. van Herpen. (2020) Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review. Cancer Treatment Reviews 89, pages 102069.
Crossref
Crossref
Assaf Moore, Yael Bar, Corinne Maurice‐Dror, Inna Ospovat, Michal Sarfaty, Yasmin Korzets, Hadar Goldvaser, Noa Gordon, Salem Billan, Orit Gutfeld & Aron Popovtzer. (2020) Next‐generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage—Multicenter experience. Head & Neck 42:4, pages 599-607.
Crossref
Crossref
Akhil Kapoor, Vanita Noronha, Anuradha Chougule, Pratik Chandrani, Omshree Shetty, VijayM Patil, Amit Joshi, Nandini Menon, Munita Bal, Richa Vaish, Amit Kumar & Kumar Prabhash. (2020) Molecular tumor board: Case 4 Salivary Gland Cancer: Novel therapeutic options as a result of comprehensive molecular profiling. Cancer Research, Statistics, and Treatment 3:3, pages 554.
Crossref
Crossref
Gerben Lassche, Wim van Boxtel, Marjolijn J.L. Ligtenberg, Adriana C.H. van Engen-van Grunsven & Carla M.L. van Herpen. (2019) Advances and challenges in precision medicine in salivary gland cancer. Cancer Treatment Reviews 80, pages 101906.
Crossref
Crossref
Amit Bahl, Naresh Kumar Panda, Arun Elangovan, Jaimanti Bakshi, Roshan Verma, Satyawati Mohindra, Rijuneeta Gupta, Arun Singh Oinam, Satinder Kaur, R. K. Vashishta & Sushmita Ghoshal. (2018) Evaluation of Multimodality Management of Adenoid Cystic Carcinoma of the Head and Neck. Indian Journal of Otolaryngology and Head & Neck Surgery 71:S1, pages 628-632.
Crossref
Crossref
Yair Israel, Adi Rachmiel, Konstantin Gourevich & Rafael Nagler. (2019) Kaplan–Meier analysis of salivary gland tumors: prognosis and long-term survival. Journal of Cancer Research and Clinical Oncology 145:8, pages 2123-2130.
Crossref
Crossref
Laura Blackwood, Aaron Harper, James Elliott & Irina Gramer. (2018) External beam radiotherapy for the treatment of feline salivary gland carcinoma: six new cases and a review of the literature. Journal of Feline Medicine and Surgery 21:2, pages 186-194.
Crossref
Crossref
Hideaki Takahashi, Yuichiro Tada, Takashi Saotome, Kohei Akazawa, Hiroya Ojiri, Chihiro Fushimi, Tatsuo Masubuchi, Takashi Matsuki, Kaori Tani, Robert Y. Osamura, Hideaki Hirai, Shuhei Yamada, Daisuke Kawakita, Kouki Miura, Shin-etsu Kamata & Toshitaka Nagao. (2019) Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma. Journal of Clinical Oncology 37:2, pages 125-134.
Crossref
Crossref
Sho Iwaki, Daisuke Kawakita, Keisuke Oguri, Akihiro Murashima, Takuma Matoba, Gaku Takano, Michi Sawabe & Shingo Murakami. (2019) Carboplatin plus Paclitaxel in patients with recurrent/metastatic head and neck carcinoma再発・転移頭頸部癌に対するCBDCA＋PTX療法の治療成績. Toukeibu Gan 45:4, pages 420-425.
Crossref
Crossref
Gustavo Schvartsman, Nathalia Almeida Pinto, Diana Bell & Renata Ferrarotto. (2018) Salivary gland tumors: Molecular characterization and therapeutic advances for metastatic disease. Head & Neck.
Crossref
Crossref
Ann-Jean C. C. Beck, Peter J. F. M. Lohuis, Abrahim Al-Mamgani, Laura A. Smit & Willem M. C. Klop. (2018) Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute. European Archives of Oto-Rhino-Laryngology 275:7, pages 1885-1892.
Crossref
Crossref
C. Fushimi, Y. Tada, H. Takahashi, T. Nagao, H. Ojiri, T. Masubuchi, T. Matsuki, K. Miura, D. Kawakita, H. Hirai, E. Hoshino, S. Kamata & T. Saotome. (2018) A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Annals of Oncology 29:4, pages 979-984.
Crossref
Crossref
Eline Boon, Wim van Boxtel, Jan Buter, Robert J. Baatenburg de Jong, Robert J. J. van Es, Miranda Bel, Edward Fiets, Sjoukje F. Oosting, Marije Slingerland, Ann Hoeben, Margot E. T. Tesselaar, Marianne A. Jonker, Uta E. Flucke, Winette T. A. van der Graaf & Carla M. L. van Herpen. (2018) Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands. Head & Neck 40:3, pages 605-613.
Crossref
Crossref